MIPS Molecular Imaging Program at Stanford

2003 Molecular Imaging Journal Club

You will need the free Adobe Acrobat Reader plugin to view the abstracts. Click on the icon Adobe PDF under the date to download the abstract.


Date Title Lab/Clinic Presenter
Dec 17, 2003
Adobe PDF
Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, Hulsbergen van de Kaa C, de la Rosette Jean, and Weissleder R. Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. N Engl J Med 2003 June;348:2491-9.
Dec 10, 2003 Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. Local gene knockdown in the brain using viral-mediated RNA interference.Nat Med. 2003 Dec;9(12):1539-44.
Dec 3, 2003
Adobe PDF
Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med. 2003 Nov;44(11):1797-803.
Nov 26, 2003
Adobe PDF
Miyagawa T, Oku T, Sasajima T, Dasai R, Beattie B, Finn R, Tjuvajev JG, Blasberg R. Assessment of Treatment Response by Autoradiography with (14)C-Aminocyclopentane Carboxylic Acid, (67)Ga-DTPA, and (18)F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model. J Nucl Med. 2003 Nov;44(11):1845-1854.
Nov 12, 2003
Adobe PDF
Wang J, Chen P, Mrkobrada M, Hu M, Vallis KA, Reilly RM. Antisense imaging of epidermal growth factor-induced p21 (WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts. Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1273-80. Epub 2003 Mar 15.
Nov 5, 2003
Adobe PDF
Burggasser G, Hurtl I, Hauff W, Lukas J, Greifeneder M, Heydari B, Thaler A, Wedrich A, Virgolini I. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease. J Nucl Med. 2003 Oct;44(10):1547-55.
Oct 29, 2003 Doubrovin M, Ponomarev V, Serganova I, Soghomonian S, Myagawa T, Beresten T, Ageyeva L, Sadelain M, Koutcher J, Blasberg RG, Tjuvajev JG. Development of a new reporter gene system--dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier. Mol Imaging. 2003 Apr;2(2):93-112.
Oct 22, 2003 Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hanscheid H, Reiners C.Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371-7. Epub 2003 Jul 15.
Oct 15, 2003
Adobe PDF
Lee KH, Byun SS, Paik JY, Lee SY, Song SH, Choe YS, Kim BT.Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging. Nucl Med Commun. 2003 Sep;24(9):1003-9.
Oct 8, 2003 Duff S, et al. CD105 is important for angiogenesis: evidence and potential applications. FASEB Journal 2003;17:984-992.
Oct 1, 2003 Bredow S, et al. Imaging of tumour neovasculature by targeting the TGF-B binding receptor endoglin. European Journal of Cancer 2000;36:675-681.
Sept 24, 2003 Buck K, et al. Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG. Journal Nuclear Medicine 2003;44:426-1431.
Sept 17, 2003 Freedman N T M, et al. Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans. European Journal Nuclear Medicine 2003;30:46-53.
Aug 20, 2003 Bird N J, et al. Indexing Glomerular Filtration Rate to Suit Children. Journal Nuclear Medicine 2003;44:1037-1043.
Aug 13, 2003 Hickeson M, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG_PET. European Journal Nuclear Medicine 2003;29:1639-1647.
July 16, 2003 Johansson L, et al. Hormesis, an update of the present position. European Journal Nuclear Medicine Imaging 2003;30:921-933.
July9, 2003 Karam M, et al. Influence of diagnostic and therapeutic doses on thyroid remnant ablation rates. Nuclear Medicine Communications 2003;24:489-495.

Stanford Medicine Resources:

Footer Links: